Inventor

CINCOTTA ANTHONY H

US87 patents

⚠️ This page may combine multiple inventors who share the name “CINCOTTA ANTHONY H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CINCOTTA ANTHONY H

UNIV LOUISIANA STATE

Therapeutic process for the treatment of the pathologies of Type II diabetes

Method of treating rheumatoid arthritis

Method of regulating the immune response

Therapeutic process for the treatment of the pathologies of type II diabetes

Therapeutic process for the treatment of the pathologies of type II diabetes

Method for regulating metabolism with dopamine beta hydroxylase inhibitors

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Method for modifying and regulating lipid metabolism

Method for modifying and resetting the bloodstream prolactin levels of a human subject

Method of regulating immune function

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebrates

Method of inhibiting body fat stores

Method for inhibiting neoplastic disease in mammals

Methods for the determination and adjustment of prolactin daily rhythms

Method for treatment of obesity using prolactin modulators and diet

Method for treatment of obesity using prolactin modulators and diet

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Process for therapeutically modifying and resetting prolactin rhythm with a dopamine agonist

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis

VEROSCIENCE LLC

Bromocriptine formulations

Method of treating metabolic disorders and depression with dopamine receptor agonists

Method of treating metabolic disorders and depression with dopamine receptor agonists

Bromocriptine formulations

Bromocriptine formulations

Method of treating metabolic disorders and depression with dopamine receptor agonists

Method of treating metabolic disorders and depression with dopamine receptor agonists

Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Bromocriptine formulations

ERGO SCIENCE INC

Method for regulating glucose metabolism

Method for modifying or regulating the glucose metabolism of an animal or human subject

Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human

Methods for the determination and adjustment of prolactin daily rhythms

Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates

GEN HOSPITAL CORP

Method of regulating immune function

Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders

Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of type II diabetes

Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders

Method for inhibiting neoplastic disease in mammals

ERGO RESEARCH CORP

Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists

Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates

SUPERVISORS OF LOUISIANA UNIVE

Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

CINCOTTA ANTHONY H

Bromocriptine formulations

Parenteral formulations of dopamine agonists

PLIVA D D

Method for the treatment of lipid and glucose metabolism disorders

SUPERVISORS OF LOUISANA STATE

Method for regulating metabolism with dopamine beta hydroxylase inhibitors

GEN HOPITAL CORP

Method of regulating immune function

MEIER ALBERT H

Method of inhibiting body fat stores